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ABSTRACT
Although adenosine has been implicated in penile erection in
human males, the receptor subtype responsible for adenosine
regulation of human corpus cavernosum (HCC) smooth muscle
tone is still a matter of debate. Using selective adenosine
agonists and antagonists, we aimed at characterizing the aden-
osine receptors mediating relaxation of precontracted (with 1
M phenylephrine) HCC strips. HCC specimens were collected
from control subjects (organ donors) and from patients with
severe vasculogenic erectile dysfunction (ED). In control sub-
jects, adenosine and 5-N-ethyl-carboxamide adenosine
(NECA) fully relaxed HCC. The selective A2A receptor agonist
2-[4-(2-p-carboxy ethyl)phenylamino]-5-N-ethylcarboxamido
adenosine (CGS21680C) produced only a partial relaxation
(30–50%) of HCC, which could be further enhanced by simul-
taneous application of 100 M NECA. The selective A2B recep-
tor antagonist N-(4-acetylphenyl)-2-[4-(2,3,6,7-tetrahydro-
2,6-dioxo-1,3-dipropyl-1H-purin-8-il)phenoxy] acetamida
(MRS1706) (10 nM) attenuated NECA-induced relaxation with-
out affecting CGS21680C action. The A2A receptor antagonist
4-{2-[7-amino-2-(2-furyl)[1,2,4]triazolo-[2,3-a][1,3,5]triazin-5-
ylamino]ethyl}phenol (ZM241385) (50 nM) consistently reduced
the actions of both agonists. In contrast to CGS21680C, NECA-
induced relaxation was attenuated when endothelial production
of NO and prostanoids was reduced by 100 M NG-nitro-L-
arginine and 10 M indomethacin, respectively. HCC strips
from patients with vasculogenic ED were partially resistant to
NECA but kept relaxation to CGS21680C; the remaining effect
was sensitive to blockade of A2A receptors with 50 nM
ZM241385. Data suggest that adenosine regulates HCC
smooth muscle tone through the activation of two receptor
populations, CGS21680C-sensitive (A2A) and -insensitive (A2B)
receptors, located on smooth muscle fibers and on endothelial
cells, respectively. Endothelial dysfunction may be correlated
with a loss of adenosine A2B receptor activity in penile vessels
from men with vasculogenic ED.
It is known that purinergic transmission is important for
initiation and maintenance of penile erection (Tong et al.,
1992). Due to its short half-life, adenosine has been used as
an agent for the diagnosis of vasculogenic impotence (Kilic et
al., 1994) without interfering with systemic blood pressure
(Takahashi et al., 1992). Extracellular adenosine may be
released from a variety of cells as result of increased meta-
bolic rates or decreased oxygen supply (Tabrizchi and Bedi,
2001) in parallel with the formation of adenosine from the
hydrolysis of released ATP through the ectonucleotidase
pathway (Zimmermann, 2000). The typical vascular response
to adenosine in many vascular beds is vasodilatation, al-
though vasoconstriction may also be seen depending on
which type of adenosine receptor is activated (Tabrizchi and
Bedi, 2001).
Four subtypes of membrane-bound adenosine receptors
(A1, A2A, A2B, and A3) have been identified by convergent
data from molecular, biochemical, and pharmacological stud-
ies (Fredholm et al., 2001). Direct effects on blood vessel tone
via adenosine actions on A1 receptors are rare and most
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frequently mediate vasoconstriction. The adenosine A3 recep-
tors are expressed in human vascular smooth muscle cells
mediating rapidly desensitizing focal vasoconstriction. It is
becoming increasingly clear that A3 receptors are not in-
volved in the relaxation of isolated blood vessels (Tabrizchi
and Bedi, 2001). The A2 receptors are coupled to Gs proteins,
and their activation results in the stimulation of adenylate
cyclase and thus vasorelaxation. A2 receptors are further
subdivided into structurally different high-affinity A2A and
low-affinity A2B receptor subtypes. The adenosine analog
CGS21680C has only very low affinity at the human A2B
receptor and is used extensively to discriminate between A2A
(Ki of 27 nM) and A2B (Ki of 88,000 nM) subtypes in humans
(Klotz, 2000). No potent and selective A2B receptor agonist
has been reported so far; 5-N-ethylcarboxamide adenosine
(NECA) is currently the most potent agonist at A2B receptor,
having low micromolar affinity (IC50  330-3100 nM) (Klotz,
2000). The xanthine amide derivative MRS1706 antagonizes
human A2B receptors with a Ki value of 1.39 nM and is
81-fold selective versus human A2A receptors (Kim et al.,
2000). This compound has been instrumental to determine
A2B receptor contribution in tissues with a mixed population
of receptors.
The receptor subtype responsible for adenosine regulation
of human cavernosal smooth muscle tone is still a matter of
debate. For example, A2A receptors might contribute to ade-
nosine-induced relaxation of human and rabbit corpus cav-
ernosum (Filippi et al., 2000), but these authors failed to
induce erection by intracavernous injection of adenosine in
human volunteers. In this study, we aimed at characterizing
the receptor subtype underlying adenosine actions on human
corpus cavernosum (HCC) in control subjects (organ donors)
and in patients with severe vasculogenic erectile dysfunction
(ED), because this condition is the most common cause of
failure to achieve erections with usual vasodilators and of
patients referred for surgical treatment.
Endothelial dysfunction is a milestone in the pathophysi-
ology of both erectile dysfunction and cardiovascular disease,
the two entities sharing a high degree of interdependence
concerning severity (Thompson et al., 2005). Adenosine and
endothelium-derived NO and prostacyclin are important lo-
cal mediators of vasodilatation. In several human vascular
beds, adenosine A2 receptors mediate vasodilatation in part
through endothelium, possibly by releasing NO (Sobrevia et
al., 1997; Li et al., 1998) and prostacyclin (Chiang et al.,
1994; Donoso et al., 2005). Other studies, however, failed to
demonstrate endothelium-dependent responses in the pres-
ence of adenosine (Sabouni et al., 1990; Tsai et al., 1996;
Kemp and Cocks, 1999). Controversy also exists on the re-
ceptor subtype (A2A or A2B) predominating on endothelial
cells (Chiang et al., 1994; Iwamoto et al., 1994; Sobrevia et
al., 1997; Li et al., 1998; Donoso et al., 2005). Since little is
known about the adenosine receptor present on endothelial
cells of HCC and the impairment of endothelium function
may be one of the factors for the attenuation of adenosine
receptor-mediated responses, we thought it would be inter-
esting to explore adenosine-induced relaxation of HCC
smooth muscle in control subjects after inhibiting endothelial
production of NO and prostacyclin compared with patients
with vasculogenic impotence exhibiting multiple risk factors
for endothelial lesion (e.g., type II diabetes, hypercholester-
olemia, hypertension, heavy smoking habits). Another impor-
tant feature of adenosine signaling is its extensive inactiva-
tion by cellular uptake and extracellular deamination in
most vascular beds, particularly by endothelial cells. There-
fore, we also investigated the kinetics of adenosine inactiva-
tion in HCC strips to probe its relevance for erectile dysfunc-
tion in patients with diffuse vascular disease.
Materials and Methods
HCC Tissues. HCC specimens were obtained from control sub-
jects (bodies donated for harvesting organs, 18–50 years) and from
patients suffering from severe vasculogenic ED (48–58 years) at the
time of penile prosthesis insertion. All the patients were informed of
procedures and signed their written consent. The protocol was ap-
proved by the Ethics Committee of Hospital Geral de Santo Anto´-
nio–SA (University Hospital) and of Instituto de Cieˆncias Biome´di-
cas de Abel Salazar (Medical School) of the University of Porto. The
investigation conforms to the principles outlined in the Declaration
of Helsinki. Tissues were maintained at 4–6°C in M-400 transplan-
tation solution not supplemented with ATP or adenosine (4.190 g/100
ml mannitol, 0.205 g/100 ml KH2PO4, 0.970 g/100 ml K2HPO43H2O,
0.112 g/100 ml KCl, and 0.084 g/100 ml NaHCO3, pH 7.4) until used,
which was between 2 and 16 h after extraction (Simonsen et al.,
1997).
Relaxation of HCC Strips. Longitudinal strips of corpus caver-
nosum tissue (3 3 7 mm) were mounted in 12-ml organ chambers
containing oxygenated (95% O2, 5% CO2, pH 7.4) Tyrode’s solution
(137 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 0.4 mM
NaH2PO4, 11.9 mM NaHCO3, 11.2 mM glucose, and 100 mM ascor-
bic acid) at 37°C. HCC strips were connected to isometric force
transducers (Hugo-Sachs, Hugstetten, Germany), and changes in
tension were recorded continuously by using either a polygraph
linearcorder (Hugo-Sachs) or a PowerLab data acquisition system
(Chart 5, version 4.2; AD Instruments, Colorado Springs, CO). Tis-
sues were preloaded with 2 g of tension and allowed to equilibrate for
90 min in Tyrode’s solution. Each strip was incrementally stretched
to optimal isometric tension, as determined by maximal contractile
response to 1 M phenylephrine (PE) (Azadzoi et al., 1992). After
standardization, relaxation to 1 to 10 M acetylcholine (ACh) was
taken as a measure of endothelium integrity. To evaluate tissue
relaxant responsiveness, HCC strips were contracted with 1 M PE,
and once a stable contraction was achieved (15–20 min) the strips
were challenged with cumulative additions of adenosine and its
stable analogs NECA or CGS21680C to the chambers by transferring
the inlet tube of the peristaltic pump from one flask to another. In
some of the experiments, HCC strips were pretreated with adenosine
receptor antagonists (MRS1706 and ZM241385) or with inhibitors of
NO synthase (L-NOARG) and inhibitors of cyclooxygenase (indo-
methacin). These compounds were tested directly on basal tone and
on 1 M PE-contracted strips to assess any contractile/relaxation
response, and they were added to the organ bath at least 15 min
before adenosine receptor agonists. Adenosine receptor antagonists
did not change constriction of HCC strips to 1 M PE, implying that
endogenous adenosine production was irrelevant under these exper-
imental conditions. Thus, adenosine deaminase was not required to
eliminate the effects of endogenous adenosine when testing the ac-
tion of the stable adenosine analogs.
Adenosine Inactivation in HCC Strips. To study the kinetics
of adenosine inactivation in HCC taken from control subjects and
from patients with vasculogenic ED, longitudinal strips (3  3  7
mm) were mounted in 1.5-ml organ baths containing oxygenated
(95% O2, 5% CO2; pH 7.4) Tyrode’s solution at 37°C. After a 30-min
equilibration period, the preparations were incubated with 30 M
adenosine (zero time). Samples of 75 l were collected from the organ
bath at different times up to 45 min for high-performance liquid
chromatography (L-6200 Intelligent pump with an L-4000 UV detec-
tor; Hitachi, Sachen, Germany) analysis of the variation of substrate
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disappearance and product formation (Magalha˜es-Cardoso et al.,
2003). Concentrations of the substrate and products were plotted as
a function of time (progress curves). The spontaneous degradation of
adenosine at 37°C in the absence of the preparation was negligible
(0–5%) over 45 min. At the end of experiments, the remaining
incubation medium was collected and used to quantify the lactate
dehydrogenase (EC 1.1.1.27) activity. The negligible (0.56  0.04
U/ml; n  7) activity of lactate dehydrogenase in bath samples
collected at the end of the experiments is an indication of the integ-
rity of the cells during the experimental procedure.
Materials and Solutions. Adenosine, ADP, AMP, ATP, 1-(4-
chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid (indometha-
cin), L-PE hydrochloride, hypoxanthine, inosine, NECA, and L-NO-
ARG were from (Sigma-Aldrich, St. Louis, MO). CGS21680C was
from Sigma/RBI (Natick, MA). Amino-3-morpholinyl-1,2,3-oxadyazo-
lio, MRS1706, and ZM241385 were from Tocris Cookson Inc. (Bristol,
UK). MRS1706 and ZM241385 were made up in 5 mM stock solu-
tions in dimethyl sulfoxide, NECA was made up in a 10 mM stock
solution in dimethyl sulfoxide, and indomethacin was made up in a
10 mM stock solution in ethanol. All stock solutions were stored as
frozen aliquots at 20°C. Dilutions of these stock solutions were
made daily, and appropriate solvent controls were done. No statisti-
cally significant differences between control experiments, made in
the absence or in the presence of the solvents at the maximal con-
centrations used [0.5% (v/v)], were observed. The pH of the superfu-
sion solution did not change by the addition of the drugs in the
maximum concentrations applied to the preparations.
Presentation of Data and Statistical Analysis. The data are
expressed as mean  S.E.M. from an n number of individuals. At
least four strips were used for each experiment. The responses are
expressed as percentage of 1 M phenylephrine contractions. For
multiple comparisons, results were analyzed by analysis of variance
followed by the Bonferroni’s post test. For comparison between two
values, the unpaired Student’s t test was used. A value of P  0.05
was considered significant.
Results
Pharmacological Characterization of Adenosine Re-
ceptors in HCC. Cumulative application of 1 to 1000 M
adenosine concentration dependently relaxed precontracted
(with 1 M PE) HCC strips from control subjects (Fig. 1, a
and b); a maximal relaxation effect of about 80% was ob-
tained with 300 M adenosine. Although maximal relaxation
of HCC strips achieved with 0.1 to 300 M NECA was similar
to that caused by adenosine (IC50 of 30 M), the nonselec-
tive A2 receptor agonist exhibited a highest potency (IC50 of
3 M) (Fig. 1a). Surprisingly, the selective A2A receptor
agonist CGS 21680C (0.001–10 M) caused only a partial
relaxation of HCC strips (IC50 of 0.03 M), which was not
greater than 30 to 50% of the maximal isometric contraction
produced by 1 M PE (Fig. 1, a and c). As illustrated in Fig.
1c, 100 M NECA was still able to cause relaxation of HCC
strips in the presence of CGS 21680C, when this drug was
used in a 10 M concentration high enough to saturate aden-
osine A2A receptors (Fig. 1a).
Preincubation with the selective adenosine A2B receptor
antagonist MRS1706 (10 nM) (Kim et al., 2000) shifted the
NECA (0.1–300 M) concentration-response curve to the
right, i.e., the IC50 values for relaxation of HCC strips calcu-
lated for NECA increased from 3 to 300 M in the presence
of 10 nM MRS1706 (Fig. 2a). Preincubation with 10 nM
MRS1706 did not significantly (P  0.05) modify relaxation
of HCC strips by 0.001 to 10 M CGS21680C (Fig. 2b). This
contrasted with that detected in the presence of the prefer-
ential A2A receptor antagonist ZM241385 (50 nM) (Poucher
et al., 1995) (Fig. 2d). Preincubation of HCC strips with 50
nM ZM241385 shifted the concentration-response curves for
both agonists to the right, NECA (0.1–300 M) and
CGS21680C (0.001–10 M); under these circumstances, the
IC50 values for the two agonists increased to 80 and 3 M,
respectively. None of the adenosine receptor antagonists sig-
nificantly changed (P  0.05) contractile responses of HCC
strips to 1 M PE, implying that endogenous adenosine was
not importantly produced. These results suggest that human
penile vessels possess two populations of adenosine recep-
tors, A2A and A2B, acting complementarily to cause smooth
muscle relaxation.
Role of the Endothelium in Adenosine-Induced Re-
laxation of HCC. At the beginning of each experiment,
Fig. 1. Relaxation of HCC strips by 1
to 1000 M adenosine and its stable
analogs NECA (0.1–300 M) and CGS
21680C (0.001–10 M). Tissue sam-
ples were collected from control sub-
jects. a, ordinates are percentage of
maximal contraction produced by 1
M PE. The vertical bars represent 
S.E.M. from an n number of separated
human specimens (four strips for each
experiment). b and c, typical record-
ing traces of relaxation of HCC strips
precontracted with 1 M PE by cumu-
lative application of adenosine (b) and
its stable analogs (c) to the incubation
fluid.
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endothelium integrity was evaluated by testing relaxation of
precontracted HCC strips to ACh. Table 1 shows that HCC
strips from control individuals relaxed to 1 to 10 M ACh in
a concentration-dependent manner. Inhibition of NO syn-
thase with 100 M L-NOARG attenuated 1 to 10 M ACh-
induced relaxation of HCC strips (Table 1), without signifi-
cantly (P 0.05) affecting relaxation caused by the NO donor
amino-3-morpholinyl-1,2,3-oxadyazolio (SIN-1; 10–30 M;
data not shown). Preincubation with 100 M L-NOARG
shifted the concentration-response curve of NECA to the
right (0.3–300 M; IC50 of 20 M) (Fig. 3a), with this effect
being more evident as the NECA concentration increased
above the micromolar range. In contrast, 100 M L-NOARG
was without effect on the ability of 0.001 to 10 M
CGS21680C to relax precontracted HCC strips (Fig. 3b). It is
worth noting that 100 M L-NOARG, like the cyclooxygenase
inhibitor indomethacin (10 M), increased contractile re-
sponses to 1 M PE by 30  4 (n  4) and 25  4% (n  4),
respectively, and their effects were additive (66  8%; n  6).
Nevertheless, attenuation of the relaxing effect of 0.3 to 300 M
NECA in the presence of 100 M L-NOARG plus 10 M indo-
methacin was not higher than that observed when HCC strips
were pretreated with each compound alone (Figs. 3a and 4). The
results suggest that endothelium-derived NO and prostacyclin
are important mediators of the CGS 21680C-insensitive aden-
Fig. 2. Concentration-response curves
of 0.1 to 300 M NECA and 0.001 to 10
M CGS21680C in HCC strips in the
absence and in the presence of selective
adenosine A2A (50 nM ZM241385) and
A2B (10 nM MRS1706) receptor antag-
onists. Tissue samples were collected
from control individuals. Adenosine
receptor antagonists were added to
the incubation fluid 15 min before ap-
plication of NECA or CGS21680C.
The ordinates are percentage of max-
imal contraction produced by 1 M
PE. The vertical bars represent 
S.E.M. from an n number of separated
human specimens (at least four strips
for each experiment). , P  0.05 com-
pared with the effect of NECA (a and
c) and CGS21680C (b and d) in the
absence of adenosine receptor antago-
nists MRS1706 and ZM241385.
TABLE 1
Relaxation of precontracted (with 1 M PE) HCC strips from control
subjects and from patients with vasculogenic ED to 1 to 10 M ACh:
the role of NO production
The NO synthase inhibitor L-NOARG (100 M) was added to the incubation media
15 min before application of ACh. Values are expressed as percentage  S.E.M. of
maximal contraction caused by 1 M PE. The number of separated human speci-
mens (four strips for each experiment) is shown in parentheses.
Control
Individuals
Patients with
Vasculogenic ED
%
No L-NOARG (100 M)
	 ACh (1 M) 53  8 (14) 81  6 (8)*
	 ACh (10 M) 43  6 (13) 67  5 (8)*
With L-NOARG (100 M)
	 ACh (1 M) 92  2 (5)* N.T.
	 ACh (10 M) 77  6 (5)* N.T.
N.T., not tested.
* P  0.05 compared with the effect of ACh in control subjects in the absence of
L-NOARG.
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osine relaxation of HCC smooth muscle, probably due to acti-
vation of the low-affinity A2B receptors on endothelial cells.
Relaxation of Cavernosal Tissue from Men with Vas-
culogenic ED to Adenosine Receptor Agonists. Patients
included in this study possess the most severe forms of ED,
requiring surgical penile implantation, because they did not
respond to common vasodilators (e.g., sildenafil and alpros-
tadil) and exhibited multiple risk factors for endothelial le-
sion (e.g., type II diabetes, hypercholesterolemia, hyperten-
sion, and heavy smoking habits). Their clinical status was
assessed by hemodynamic studies. Endothelial dysfunction
was confirmed in vitro at the beginning of each experiment
by a significant (P  0.05) reduction to relaxation induced by
ACh, even when this drug was used in high concentrations (10
M) (Table 1). In some experiments, 10M ACh was also tested
after application of adenosine receptor agonists for proving its
inability to increase relaxation of HCC strips beyond that pre-
viously caused by activating adenosine receptors (Fig. 5).
In contrast with the findings obtained in control individu-
als, 0.1 to 300 M NECA-induced relaxations of HCC strips
from patients with vasculogenic ED were incomplete, i.e.,
maximal relaxations produced by NECA in these patients did
not surpass 30 to 50% of full contractions caused by 1 M PE
(Fig. 6a). Moreover, the effect of 0.1 to 300 M NECA was not
modified after preincubation of HCC strips from patients
with vasculogenic ED with the selective A2B receptor antag-
onist MRS1706 (10 nM) (Fig. 7a). There were no significant
(P  0.05) differences between the concentration-response
curves for the effect of 0.001 to 10 M CGS21680C in HCC
strips from control subjects and from patients with vasculo-
genic ED (Fig. 6b), but the selective A2A receptor antagonist
ZM241385 (50 nM) was still able to attenuate 0.001 to 10 M
Fig. 4. Effect of cyclooxygenase inhibition with 10 M indomethacin on
the concentration-response curve of 0.1 to 300 M NECA. HCC strips
were collected from control subjects. Indomethacin (with or without L-
NOARG) was added to the incubation fluid 15 min before application of
NECA. The ordinates are percentage of maximal contraction produced by
1 M PE. The vertical bars represent  S.E.M. from an n number of
separated human specimens (at least four strips for each experiment). ,
P  0.05 compared with the effect of NECA in control conditions.
Fig. 5. Representative recordings of the relaxation of HCC strips precon-
tracted with 1 M PE by cumulative application of 0.1 and 1 M
CGS21680C, 0.1 and 1 M NECA, and 1 and 10 M ACh. The tissue
sample was collected during surgical implantation of penile prosthesis
from a 49-year-old patient (RMJ) with vasculogenic ED. RMJ was a heavy
smoker (80 cigarettes/day) and had a clinical history of noncontrolled
chronic hypertension, type II diabetes (with 3 years of evolution with
metformin), hypercholesterolemia (medicated with lovastatin), and se-
vere iliac artery disease.
Fig. 3. Concentration-response
curves of 0.1 to 300 M NECA and
0.001 to 10 M CGS21680C in the
absence and in the presence of the NO
synthase inhibitor L-NOARG (100
M). HCC strips were collected from
control subjects. L-NOARG was added
to the incubation fluid 15 min before
application of NECA or CGS21680C.
The ordinates are percentage of max-
imal contraction produced by 1 M
PE. The vertical bars represent 
S.E.M. from an n number of separated
human specimens (at least four strips
for each experiment). , P  0.05 com-
pared with the effects of NECA (a)
and CGS21680C (b) in the absence of
L-NOARG.
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CGS21680C-induced relaxation of HCC strips from patients
with vasculogenic ED (Fig. 7b). It is also worth noting that
maximal relaxations produced by 0.1 to 300 M NECA and
0.001 to 10 M CGS21680C were of a similar magnitude if one
considers the samples from patients with vasculogenic ED. This
contrasts with that observed in control subjects where NECA
had about twice the efficacy of CGS21680C (Fig. 6).
For comparison, we also tested the effects of adenosine and
its stable analogs NECA and CGS 21680C on HCC strips
from two patients with nonvasculogenic ED. Viable cavern-
osal tissue samples were obtained either during partial am-
putation of the penis due to in situ carcinoma (JPF, 52 years,
history of traumatic paraplegia with 15 years of evolution) or
during penile prosthesis insertion using the same surgical
procedure as in the other patients with vasculogenic ED in a
patient (MJSG, 58 years) submitted to surgical ablation of
the prostate gland 4 years before. The two patients re-
sponded to local application of vasodilators, and endothelial
integrity was confirmed in vitro by a positive relaxation to 1
to 10 M ACh. The efficacy profile of the adenosine receptor
agonists was similar to that observed in HCC strips from
control subjects (data not shown).
Kinetics of Adenosine Inactivation in HCC Tissue.
The progress curves of 30 M adenosine disappearance in HCC
strips from control subjects and from vasculogenic ED patients
are represented in Fig. 8. The results show that extracellular
adenosine is slowly inactivated in HCC compared with other
tissues (e.g., human urinary bladder) (Faria et al., 2005). There
were no significant (P  0.05) differences between the rate of
adenosine inactivation and metabolites (inosine and hypoxan-
thine) formation in the two groups of samples (Fig. 8, a and b).
Forty-five minutes after 30 M adenosine application, the con-
centration of the nucleoside in the incubation fluid was 26.76
1.42 and 27.78 2.13 M, respectively, in samples from control
subjects and from vasculogenic ED patients, whereas inosine
concentrations in the two groups were 3.49  0.94 and 3.50 
1.00 M, respectively. The absence of AMP formation from
adenosine suggests that no extracellular adenosine kinase (EC
2.7.1.20) activity is present in HCC.
Discussion
This study is pioneering by the use of selective adenosine
agonists and antagonists for the characterization of adeno-
Fig. 6. Concentration-response
curves of 0.1 to 300 M NECA and
0.001 to 10 M CGS21680C in HCC
strips obtained from control subjects
and from vasculogenic ED patients.
The ordinates are percentage of max-
imal contraction produced by 1 M
PE. The vertical bars represent 
S.E.M. from an n number of separated
human specimens (at least four strips
for each experiment). , P  0.05 com-
pared with the effects of NECA (a)
and CGS21680C (b) in control sub-
jects.
Fig. 7. Adenosine-induced relaxation
of precontracted HCC strips from pa-
tients with vasculogenic ED is atten-
uated by blocking adenosine A2A re-
ceptors but not the A2B receptors.
ZM241385 (50 nM; A2A receptor an-
tagonist) and MRS1706 (10 nM; A2B
receptor antagonist) were added to
the incubation fluid 15 min before ap-
plication of 0.1 to 300 M NECA (a)
and 0.001 and 10 M CGS21680C (b),
respectively. The ordinates are per-
centage of maximal contraction pro-
duced by 1 M PE. The vertical bars
represent  S.E.M. from an n number
of separated human specimens (at
least four strips for each experiment).
, P 0.05 compared with the effect of
NECA (a) and CGS21680C (b) in the
absence of adenosine receptor antago-
nists.
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sine receptors in the human cavernosal tissue. The agonist
efficacy profile to cause relaxation of HCC strips from control
subjects was NECA  adenosine  CGS21680C. NECA and
adenosine relaxed HCC strips by about 80% of the maximal
contractile response to PE, whereas CGS21680C produced
only a 30 to 50% relaxation. Suspicion of the existence of two
populations of adenosine receptors acting cooperatively to
cause relaxation of HCC strips was further confirmed by the
additive effects of NECA and CGS21680C, when the latter
compound was used in a concentration (10 M) high enough
to saturate A2A receptors. Moreover, blockade of A2B recep-
tors with 10 nM MRS1706 shifted the concentration-response
curve of NECA to the right, without significantly modifying
CGS21680C relaxation. The nonxanthine antagonist
ZM241385 (50 nM), exhibiting a high affinity for the A2A
receptor (pKB of 9) (Poucher et al., 1995), attenuated the
relaxing effects of NECA and CGS21680C, because it has
only 22-fold selectivity for human A2A over A2B receptors
(Linden et al., 1999). As far as we know, this is the first study
to suggest the involvement of two subtypes of adenosine
receptors, high-affinity A2A and low-affinity A2B, in the re-
laxation of cavernosal vessels of the human penis. Receptor
heterogeneity might explain some controversies found in the
literature concerning the efficacy profile of nonselective
adenosine agonists (e.g., NECA) on erectile tissues of human
and other species (Mantelli et al., 1995; Filippi et al., 2000;
Andersson, 2001; Noto et al., 2001).
The etiology of vasculogenic ED has been associated to
reduced NO formation either from nonadrenergic noncholin-
ergic nerve fibers or from endothelial cells of cavernosal
vessels (Gonzalez-Cadavid et al., 1999; Cashen et al., 2002).
Penile smooth muscle relaxation produced by some endoge-
nous mediators, such as adenosine via A2B receptors (Chiang
et al., 1994), is operated by endothelial NO formation trig-
gered by activation of NO synthase secondary to phosphory-
lation by protein kinase A or to increases in intracellular
Ca2	. In this context, we investigated whether adenosine-
induced relaxation of HCC strips could be mediated by NO
production and what would be the receptor subtype involved.
Data suggest that activation of A2B receptors, which are
insensitive to CGS 21680C, requires endothelial NO produc-
tion to cause relaxation of HCC strips. Adenosine may also
relax HCC strips acting directly through A2A receptors on
smooth muscle fibers in an NO-independent manner, like
that observed in the rabbit penile vessels (Mantelli et al.,
1995) and in the anesthetized dog (Noto et al., 2001).
HCC tissue can synthesize prostanoids (for review, see
Andersson, 2001; Jeremy et al., 1986), and their actions may
be impaired in tissues previously treated with the cyclooxy-
genase inhibitor indomethacin (10 M) (Angulo et al., 2002).
Prostanoids are involved in the regulation of penile smooth
muscle contractility by way of specific receptors. Thrombox-
ane A2 (TP) receptors mediate contraction, whereas relax-
ation of HCC strips and human penile resistant arteries are
mediated by prostaglandin E2 (EP) and/or prostacyclin (IP)
receptors, respectively. Enhancement of HCC strips contrac-
tility from control individuals to 10 M indomethacin sug-
gests a high output of relaxant prostanoids in this tissue,
whereas the synthesis of contractile prostanoids (thrombox-
ane A2 and prostaglandin F2) might not play a relevant role
(Angulo et al., 2002). Although cases of indomethacin-asso-
ciated sexual dysfunction have been reported previously
(Miller et al., 1989), treatment with nonsteroidal anti-inflam-
matory drugs is not as commonly implicated in ED as might
be predicted. This discrepancy may result from increased
production of endogenous prostanoids when oxygen tension
in the buffer solution is near saturation (95% O2) (Daley et
al., 1996). Our results showed that, although A2B receptor-
mediated relaxation can be partially dependent on the pro-
duction of NO and prostanoids by the endothelium, inhibition
of the two pathways with 100 M L-NOARG plus 10 M
indomethacin did not further reduce NECA activity, because
they might be mutually exclusive. Hemodynamic studies in
men showed that penile tumescence due to intracavernosal
application of prostaglandin E1 for treating impotence could
be enhanced by adenosine (Chiang et al., 1994), since the
nucleoside acts synchronously via smooth muscle fibers and
endothelial cells.
Fig. 8. Extracellular inactivation of
30 M adenosine in HCC strips ob-
tained from control subjects (a) and
from patients with vasculogenic ED
(b). Adenosine (30 M) was added at
zero time to the preparations. Bath
samples were collected at the times
indicated on the abscissa, for high-
performance liquid chromatography
analysis to separate and quantify the
substrate and its metabolites. The
adenosine metabolites were mainly
inosine (INO) and a negligible amount
of hypoxanthine (HX). The data are
means  S.E.M. of an n number of
separated human specimens.
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Pharmacological heterogeneity and differential distribu-
tion of adenosine receptors through distinct layers of the
penile vessel wall prompted us to investigate adenosine-in-
duced relaxation in HCC strips from patients with ED pre-
senting multiple risk factors for endothelial lesion. HCC
strips from vasculogenic ED patients were partially resistant
to NECA but kept relaxation to CGS21680C, and they were
sensitive to blockade by the A2A antagonist ZM241385 (50
nM). In contrast to control subjects, maximal relaxation by
NECA had a similar magnitude (30–50%) to that caused by
the selective A2A receptor agonist CGS21680C. Although the
A2B receptor antagonist MRS1706 (10 nM) antagonized
NECA-induced relaxation in HCC strips from control sub-
jects, it was devoid of effect on tissues isolated from patients
with vasculogenic ED. Likewise, Chiang et al. (1994) showed
that adenosine action (probably via A2B receptors) was
greater in intact than in endothelium-denuded rabbit corpora
cavernosa, suggesting the involvement of an endothelium-
derived relaxing factor. The ability of adenosine analogs to
cause relaxation of HCC strips from age-matched patients
with nonvasculogenic ED was also evaluated, but their ef-
fects were not significantly different from controls. These
results constitute the first experimental evidence of a close
relationship between endothelial dysfunction and the loss of
A2B receptors activity in penile vessels from vasculogenic ED
patients. Whether this reflects a reduction of A2B receptor
binding sites or results from impairment of distal effectors
pathways needs further investigation. Dysfunctional blood
vessels can alter the balance between relaxant and constric-
tor actions of endogenous prostanoids (Azadzoi et al., 1998;
Behr-Roussel et al., 2003). This, together with the reduced
NO-mediated component, might explain the difficulty in re-
laxing HCC strips from vasculogenic ED patients in response
to NECA and ACh. Maintenance of relaxation to CGS21680C
opens new perspectives for the pharmacological management
of severe forms of vasculogenic ED. Targeting adenosine A2A
receptors located on the smooth muscle layer may be an
interesting strategy to overcome resistance to common vaso-
dilators (e.g., sildenafil and alprostadil) requiring NO pro-
duction by intact endothelial cells (Rosen and Kostis, 2003).
Extracellular inactivation by cellular uptake and extracel-
lular deamination may restrict adenosine actions to the re-
lease/production sites and may limit diffusion of the exog-
enously added nucleoside toward the receptor zones (Daly,
1982; Duarte-Arau´jo et al., 2004). This could be one of the
factors for the limited time window of adenosine responses in
corpora cavernosa and for the lack of systemic blood pressure
repercussions following intracavernous injection of the nu-
cleoside. Because we hypothesized that human penile vessels
possess two subtypes of adenosine receptors acting coopera-
tively to regulate smooth muscle tone, a high-affinity recep-
tor (A2A) located on smooth muscle fibers and a low-affinity
receptor (A2B) present at endothelial cells, and the functional
equilibrium between these two receptors may be altered in
patients with severe vasculogenic ED, we investigated the
kinetics of adenosine inactivation in HCC strips to probe its
role in the pathophysiology of ED. Extracellular adenosine
was slowly, but stoichiometrically, converted into inosine by
ectoadenosine deaminase with a similar kinetics in HCC
strips from both control subjects and patients with vasculo-
genic impotence. These results also indicate that the nucle-
oside transport system does not play a major role in adeno-
sine inactivation in human cavernosal vessels, which is in
contrast with the findings obtained in many other vascular
beds. Therefore, adenosine clearance to the main blood-
stream and/or the nucleoside inactivation by several blood
elements might be the major contributors for adenosine dis-
appearance in the human penis. The slow inactivation kinet-
ics in HCC implies that adenosine might play a significant
role to control blood supply to penile vessels in men with
vasculogenic impotence. This hypothesis is in keeping with
clinical studies showing that intracavernosal application of
adenosine maintains competent penile erection that exclu-
sively depends on the activity of membrane-bound adenosine
receptors (Takahashi et al., 1992) for a period of 5 to 13 min,
which is enough to facilitate performance of hemodynamic
tests (Kilic et al., 1994). It remains, however, to be elucidated
whether endogenous adenosine reaches high enough levels to
activate the low-affinity A2B receptor. The relative contribu-
tion of A2B receptors might be greater during initiation of
penile tumescence following a period of flaccidity, where ox-
ygen supply is much lower (30–40 mm Hg) than that ob-
served on full erection (100 mm Hg).
In conclusion, this work is pioneering 1) in studying the
kinetics of extracellular inactivation of adenosine in HCC
and 2) in characterizing the adenosine receptor subtypes
responsible for relaxation of penile vessels. By comparing the
magnitude of adenosine relaxation of HCC strips from con-
trol subjects and from vasculogenic ED patients, it is con-
cluded that endothelial dysfunction may be correlated with
the loss of adenosine A2B receptors activity, keeping unal-
tered relaxation of cavernosal vessels via A2A receptors prob-
ably located on the smooth muscle layer. Although direct
evidence of regional adenosine receptors distribution in hu-
man penile vessels requires further studies, the information
from the present study may help to delineate new pharma-
cological strategies to manage severe vasculogenic impotence
resistant to common vasodilators.
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